1 min read.Updated: 22 Apr 2021, 02:26 PM ISTStaff Writer( with inputs from Reuters )
Pfizer said it had offered India a not-for-profit price for its vaccine for the government's immunisation programme
Pfizer is in discussions with India and committed to make its COVID-19 vaccine available for deployment in the country, Reuters cited the US drugmaker as saying. The company said it had offered India a not-for-profit price for its vaccine for the government's immunisation programme.
Last week, the Indian government said it would fast-track emergency approvals for foreign-made COVID-19 vaccines, a move that would exempt companies from carrying out "bridging" trials for their vaccines.
This week, Prime Minister Narendra Modi urged state governments to use lockdowns as a last resort. He asked people to stay indoors and said the government was working to increase the supply of oxygen and vaccines.
Meanwhile, Pfizer has announced that it will supply an additional 100 million doses of its COVID-19 vaccine to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its expanded Advanced Purchase Agreement signed on February 17, 2021. This brings the total number of doses to be delivered to the EU to 600 million.
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Never miss a story! Stay connected and informed with Mint.
our App Now!!